September has a reputation, and this year it comes with a calendar. The CPI print lands September 11 and the Fed’s rate decision follows on September 16, either one can move the whole market regardless of how carefully you picked individual names. I can’t hand you five stocks that are immune to a market-wide selloff, because that stock doesn’t exist. What I can do is build a list engineered against the other kind of damage: the single-stock blow-up, the earnings surprise, the legal landmine, the concentrated bet that unravels overnight. This list puts win rate ahead of upside. If you want five names that could double, this isn’t that article.
The screening logic
Every name here had to clear four filters:
- No earnings report scheduled in September. A surprise quarterly miss is the most common trigger for a single stock dropping 10%-plus in one session.
- Beta meaningfully below 1.0 — historically moves less than the market in both directions.
- A business insulated from a single product cycle or one big customer.
- Where possible, a recently resolved overhang rather than an open one. A settled lawsuit or a digested guidance cut is a very different risk than an unanswered question hanging over the stock.
| Stock | Beta | Next earnings | Why it’s here |
|---|---|---|---|
| Berkshire Hathaway (BRK.B) | 0.60 | ~Nov 7 | Diversification inside one ticker |
| NextEra Energy (NEE) | 0.65 | ~Oct 26 | Regulated utility, dividend pays Sept 15 |
| Johnson & Johnson (JNJ) | 0.26 | ~Oct | Lowest beta; talc overhang resolved |
| Walmart (WMT) | 0.60 | ~Nov 18 | Bad news already delivered Aug 21 |
| Church & Dwight (CHD) | ~0.4 | ~Oct/Nov | Mid-cap staples, technical base |
Berkshire Hathaway (BRK.B): the anchor
Berkshire closed at $504.91 on August 26, with a beta of 0.60, a trailing P/E of 12.68, sitting mid-range in its 52-week band of $464 to $538 and above its 200-day average. The detail that matters for this list: the next earnings report isn’t expected until around November 7, so all of September sits outside any single-day earnings risk.
What makes it a win-rate pick rather than a low-beta placeholder is the diversification built into the business. GEICO insurance, BNSF freight rail, Berkshire Hathaway Energy, and a public equity book that Greg Abel’s team has been reshaping, including roughly $10 billion of Alphabet bought directly from the company in a private placement, all sit under one ticker. A bad news cycle in any one segment gets absorbed by the others. For the framework behind picks like these, see how I build a stock-picking system.
NextEra Energy (NEE), the regulated utility
NextEra trades with a beta of 0.65, a market cap near $176 billion, and a trailing P/E around 19, below the market average. Utilities earn a place on a list like this because they’re structurally insulated from discretionary spending swings. NextEra’s Q2 2026 results, reported July 24, showed adjusted EPS up roughly 9.5% year over year, and the next report isn’t due until late October.
There’s a catalyst inside September itself: the board declared a $0.6232 quarterly dividend with an August 28 ex-date and a September 15 payment. The stock is up about 13% over the trailing year, ahead of its utility peers, and the pending Dominion Energy merger adds a longer-term growth angle without near-term event risk.
Johnson & Johnson (JNJ): the lowest beta here
JNJ carries a beta of just 0.26, the most defensive name in the group, trading around $266 to $270 with a market cap near $635 billion. It has raised its dividend for more than 60 consecutive years, a streak that survives recessions and rate cycles by design.
The reason it earns a spot now specifically is that a major overhang just closed rather than staying open. The company reached a talc-related settlement reported at $5.5 billion or more, ending years of litigation uncertainty that had weighed on sentiment. A settled liability is a different risk profile than a pending one. Combined with recent FDA approval for Imaavy and continued oncology strength from Darzalex and Carvykti, this is a business with real pipeline momentum and one fewer wildcard heading into a volatile month.
Walmart (WMT), where the bad news is already out
This one needs an explanation, because a stock that just fell about 9% doesn’t sound like a low-volatility idea. Walmart reported Q2 on August 21, beating on EPS ($0.81 versus a $0.74 estimate), but shares dropped on margin-quality concerns and softer comparable sales. The next earnings report isn’t expected until around November 18, so September sits in a news vacuum after the selloff rather than ahead of an unknown catalyst.
“Avoid black swans” and “buy right before the news event” are opposite strategies, and Walmart just had its news event. Beta sits at 0.60, the dividend-aristocrat status is intact, and with a worst-case reaction already in the price and no fresh catalyst until well past September, this looks more like a stock that has absorbed its shock than one still waiting to deliver it.
Church & Dwight (CHD): the mid-cap
Church & Dwight adds genuine market-cap diversification to the list. CNBC technical strategist Katie Stockton flagged it in early August as a low-beta consumer-staples standout heading into a potentially volatile quarter. The stock cleared resistance on her weekly model, with the 200-day moving average near $93 as a defined risk floor and resistance around $106 and $114 above.
Some analysts have trimmed fair value modestly, from about $120 to $114, citing a softer staples backdrop. That’s the kind of caution that supports a win-rate thesis rather than undermining it: a stock isn’t a black-swan risk because expectations were already lowered. The danger sits in the names where they haven’t been.
Check the picks yourself
Don’t take any of this on faith. Run each ticker through the free quant rating tool. Because this list is built around limiting downside rather than chasing upside, it’s worth raising the weight on Profitability, Financial Health and Valuation and lowering Momentum and Sentiment before you read the score, that setup surfaces whether the balance sheet and earnings quality actually support the defensive case, rather than short-term price action. The Volatility factor is calculated straight off beta, so you can confirm independently that all five score the way I’ve described.
The caveat
None of this removes September 11 and September 16 as real, scheduled, market-wide risk. A hawkish Fed or a hot CPI print can drag every one of these lower for a session or two no matter how clean the fundamentals. What the list is built to avoid is the second layer of risk, the company-specific disaster that has nothing to do with the Fed and everything to do with a surprise miss, an open lawsuit, or a one-product bet gone wrong. Five stocks, five corners of the market, no September earnings dates between them, and a beta profile that should move well less than the index in either direction on a normal day.
Financial disclaimer: The content on StockVane is for educational and informational purposes only and should not be construed as professional financial advice. Stock market investing involves risk of loss.